Cohort 
2023

Carlos Coronel, PhD

Neuroscientist

To reduce the scale and impact of dementia, we need to promote collaborative efforts and develop novel and affordable biomarkers for underserved and underrepresented populations.

Current Work

Carlos is a postdoctoral researcher at the Latin American Brain Health Institute (BrainLat), Chile. He is researching new biomarkers using electroencephalography and mathematical models.

Personal Hero

Tuomas Holopainen

Words of Strength

Lead, encourage, empower, create, inspire

Vision

Carlos believes that to reduce the scale and impact of dementia, we need to promote collaborative efforts, and develop novel and affordable biomarkers for underserved and underrepresented populations.

Strategy

Carlos is using mathematical models and electroencephalography to identify possible biomarkers of dementia. This can help in the development of novel therapeutic targets for neurodegenerative diseases.

Impact

As an Atlantic Fellow, Carlos aims to gain a deeper understanding of socioeconomic and biological risk factors of dementia. He wants to boost neuroscience research in Latin America, and reduce the impact of dementia in the region.

Motivation

Dementia is facing rapid growth in Latin America, a highly diverse region underrepresented in dementia research. Region-specific and robust biomarkers are critical to provide a precise and early diagnosis of dementia.

Education & Experience

Carlos holds a bachelor's degree in Biology (Universidad de Carabobo, Venezuela), and a PhD in Biophysics and Computational Biology (Universidad de Valparaíso, Chile). He is currently working as a postdoctoral researcher at the BrainLat Institute (Universidad Adolfo Ibáñez, Chile).

Universidad de Valparaíso
Biophysics and Computational Biology
PhD
Universidad de Carabobo
Biology
Bachelor's degree